Challenges and opportunities in biomarker-driven trials: adaptive randomization

ABSTRACT: In an era of precision medicine, as advanced technology such as molecular profiling at individual patient level has been developed and become increasingly accessible and affordable, biomarker-driven trials have been received a lot of attention and are expected to receive more attention in order to integrate clinical practice with clinical research. Biomarkers play a critical role to identify patients who are expected to get benefit from a treatment, and it is important to effectively incorporate the biomarkers into clinical trials to understand the biomarker-treatment relationship and increase the efficiency. We investigate incorporating biomarkers in adaptive randomization to identify patients who would respond better to the treatment and optimize the treatment allocation. The covariate-a

SUBMITTER:  

PROVIDER: S-EPMC9577777 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature